The Claim
Fisetin supplementation at 200 mg/day for 12 weeks without concurrent exercise reduces interleukin-6 by 8.8% and tumor necrosis factor-alpha by 36.1% in obese men, and has no significant effect on Maresin-1 levels or insulin sensitivity compared to placebo.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese men, taking 200 mg of fisetin daily for 12 weeks without exercise lowers interleukin-6 by 8.8% and tumor necrosis factor-alpha by 36.1%, but does not change Maresin-1 levels or insulin sensitivity more than a placebo.
See the scientific wording
Fisetin supplementation (200 mg/day) for 12 weeks without exercise reduces interleukin-6 by 8.8% and tumor necrosis factor-alpha by 36.1% in obese men, but does not significantly increase Maresin-1 or improve insulin sensitivity beyond placebo levels.
Fisetin blocks a key inflammation switch in fat and immune cells, which stops the production of harmful signaling molecules. It also protects essential fats from damage, allowing the body to naturally calm inflammation without needing exercise.
What the research says
1 studyThe study found that taking fisetin alone, even without exercise, lowered inflammation and improved insulin sensitivity — but the claim says it doesn’t. So the claim is wrong.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.